FCA: forget chemoimmunotherapy with alemtuzumab?
Blood
.
2012 May 31;119(22):5059-60.
doi: 10.1182/blood-2012-04-413096.
Author
Michael Hallek
1
Affiliation
1
University of Cologne.
PMID:
22653949
DOI:
10.1182/blood-2012-04-413096
No abstract available
Publication types
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
Leukemia, Lymphocytic, Chronic, B-Cell / mortality*
Male